Entia is an oncology service provider supporting more effective cancer care by predicting and preventing treatment side effects. The company was founded in 2015 to address challenges in remote patient monitoring, including the world's first at-home full blood count analyser, identify patients at risk of complications early on and enable timely interventions that can result in more time on treatment, fewer unplanned hospitalisations and the potential deliver better survival outcomes.

Its blood count analyser, The Liberty, is approved for UK launch.